Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 1466-1472, July 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomisek, A. J.
Right arrow Articles by Allan, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomisek, A. J.
Right arrow Articles by Allan, P. W.

Deoxyribonucleic Acid Synthesis

I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic Acid Synthetase System of Sensitive and Resistant Plasmacytomas1

Arthur J. Tomisek, Martha Bruce Irick and Paula Wedeles Allan

Kettering-Meyer Laboratory, Southern Research Institute,2 Birmingham, Alabama

We have shown that the in vivo treatment of Fortner plasmacytomas with cyclophosphamide can lead to strong inhibitions of both deoxyribonucleic acid nucleotidyl transferase and thymidylate kinase activities in the soluble cell fractions. However, in allowing only 2 hr for the inhibitor to act, the effect observed on the transferase was an unexplained stimulation rather than an inhibition.

We have also provided some evidence that the inhibition of growth precedes the inhibition of deoxyribonucleic acid nucleotidyl transferase activity.

1 This investigation was supported by grants from the Alfred P. Sloan Foundation, the Charles F. Kettering Foundation, The John A. Hartford Foundation, Inc., and by the Cancer Chemotherapy National Service Center, National Cancer Institute, under the National Institutes of Health Contract No. SA-43-ph-2433. A preliminary report was presented before the American Association for Cancer Research, Chicago, Illinois, April 1964.

2 Affiliated with the Sloan-Kettering Institute, New York, New York.

Received 6/21/65. Revised 1/10/66.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.